Sign in
Create a Profile
Study of Blood Samples From Newborns With Down Syndrome
Diseases and Conditions Researched
Down Syndrome; Leukemia
What is the purpose of this trial?
RATIONALE: Studying the genes expressed in samples of blood from patients with Down syndrome may help doctors identify biomarkers related to cancer.
PURPOSE: This research study is looking at blood samples from newborns with Down syndrome.
Participation Guidelines
| Sponsors: | Children's Oncology Group; National Cancer Institute (NCI) |
|---|---|
| Dates: | August 13, 2009 |
| Last Updated: | December 21, 2011 |
| Study HIC#: | 1112009391 |
| Clinicaltrials.gov ID: | NCT00959283 |
How will my information be used?
For more information about this trial, contact:
Clinical Trials Office - Yale Cancer Center
203-785-5702
Principal Investigator
Nina Kadan-Lottick
Pediatrics
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.
